Unexplained weight loss (UWL), defined as a loss of 5% or more of total body weight within a six-month period without trying, poses a diagnostic challenge in clinical practice. It is often a harbinger of serious underlying conditions, necessitating a comprehensive and systematic approach to its evaluation.
UWL can be attributed to a myriad of causes, including malignancies, gastrointestinal disorders, endocrine abnormalities, psychiatric illnesses, and infections. The initial evaluation should incorporate a detailed history, physical examination, and basic laboratory tests. It is crucial to ascertain the timeline, associated symptoms, and potential risk factors to guide further investigations.
The diagnostic approach to UWL should be patient-centered and guided by clinical judgment. If initial tests are inconclusive, consider targeted investigations based on symptomatology. For instance, imaging studies in the presence of abdominal pain or endocrine tests for symptoms suggestive of hyperthyroidism. Nevertheless, in about 15-25% of cases, the cause remains elusive despite extensive workup.
Management should be tailored to the underlying cause, if identified. In idiopathic UWL, periodic monitoring for the emergence of new symptoms or signs is recommended. Nutritional support and pharmacotherapy may be beneficial in managing symptoms and improving quality of life.
Decoding the cause of UWL requires a meticulous and patient-specific approach, underpinned by a thorough understanding of its diverse etiology. While it can be a diagnostic conundrum, a systematic approach can enhance diagnostic accuracy, facilitate timely management, and ultimately improve patient outcomes. Further research is warranted to refine diagnostic strategies and to elucidate the pathophysiology of idiopathic UWL.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation